Dr. Zackon on Targeted Therapies

Apr 27, 2015

Dr. Ira Zackon, Director of NYOH’s Stem Cell Transplant Program, and patient Gary Vogt were recent guests on WMHT’s Health Link program, discussing the topic of targeted therapy, a new development in cancer treatment that is based on a patient’s individual genetic makeup.

After being diagnosed with Myelofibrosis,  a disease in which abnormal blood cells and fibers build up inside the bone marrow, Dr. Zackon started Gary on a targeted therapy that has been highly successful in keeping his disease in check. NYOH is also involved in clinical trials involving emerging targeted therapies.

Watch the Health Link program

About Dr. Ira Zackon, Director of NYOH Stem Cell Transplant Program